
The two-year search for a new chair of the Competition and Markets Authority will end later this month with the expected appointment of Clive Bannister, allowing the focus to switch to finding a successor for the UK competition watchdog’s outgoing chief executive Andrea Coscelli.
The government is set to announce Bannister, the former chief executive at insurance firm Phoenix Group, as the replacement to Andrew Tyrie, who was ousted in 2020 after a boardroom coup, according to several individuals with knowledge of the process.
The protracted search for a new chair has led to further disruption at the top of the regulator by hampering the process to replace Coscelli, who announced at the start of the year that he would step down in July. As a result, the government has opted to appoint an interim chief executive with Sarah Cardell, the CMA’s general counsel, the leading candidate, according to these people.
Officials are keen for the chief executive’s role to be filled by a woman, and while the new chair will have a key role in the search, Cardell has strong internal backing to take the role permanently, according to the same people. The government is not expected to start the official search for a permanent chief executive until after the summer, however.
The lack of orderly succession planning at the CMA comes at a crucial time as its expands its role in the wake of Brexit and the world’s leading competition watchdogs seek to rein in big technology companies like Facebook and Google.
But there are other potential candidates and those with knowledge of the process warned that Cardell’s appointment was not certain given that the final decision rests with business secretary Kwasi Kwarteng.
Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.
Featured News
Meta Begins Defense After FTC Concludes Case in Landmark Antitrust Trial
May 15, 2025 by
CPI
UK Data Bill Still No Closer to Passage As Parliamentary ‘Ping-Pong’ Drags On
May 15, 2025 by
CPI
Regeneron Pharmaceuticals Awarded $271.2M in Damages Against Amgen
May 15, 2025 by
CPI
FTC Chair Proposes 15% Staff Reduction Amid Budget Constraints
May 15, 2025 by
CPI
UK Urges Antitrust Watchdog to Prioritize Growth and Clarity in Business Regulation
May 15, 2025 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Healthcare Antitrust
May 14, 2025 by
CPI
Healthcare & Antitrust: What to Expect in the New Trump Administration
May 14, 2025 by
Nana Wilberforce, John W O'Toole & Sarah Pugh
Patent Gaming and Disparagement: Commission Fines Teva For Improperly Protecting Its Blockbuster Medicine
May 14, 2025 by
Blaž Višnar, Boris Andrejaš, Apostolos Baltzopoulos, Rieke Kaup, Laura Nistor & Gianluca Vassallo
Strategic Alliances in the Pharma Sector: An EU Competition Law Perspective
May 14, 2025 by
Christian Ritz & Benedikt Weiss
Monopsony Power in the Hospital Labor Market
May 14, 2025 by
Kevin E. Pflum & Christian Salas